Evening Primrose Oil: Evidence, GLA and Safety

A label can name the oil, a constituent such as GLA, or a blend. Record exactly what each amount refers to and whether it is per capsule or per serving. The total oil amount and the GLA amount describe different things; do not treat the two numbers as interchangeable.^{See reference 1,See reference 3}

For a hypothetical label that states both amounts, compare the named ingredient before comparing the number. A larger oil figure does not automatically establish more GLA, and neither number alone establishes a benefit. This is label-reading logic, not a supplement prescription.^{See reference 1,See reference 3}

Cochrane examined 27 studies with 1,596 adults and children across evening primrose and borage oil combined; that is not the participant count for evening primrose alone. The review looked at eczema symptoms, with quality-of-life data in only two evening primrose trials. Short-term tolerability does not settle long-term safety.^{See reference 2}

When reading a product claim, identify the route, ingredient and outcome in its cited study. “Contains GLA” describes composition. “Improves eczema” describes an effect. Evidence for the first statement cannot substitute for evidence for the second.^{See reference 1,See reference 2}

Stomach pain, nausea and diarrhoea can occur. Medicines may interact with the oil. Pregnancy and breastfeeding evidence is inconclusive, and use in children is less understood. Studies around labour are inconsistent; they do not establish a safe self-directed method.^{See reference 1}

Quality seals can address manufacturing or ingredient checks, but do not guarantee safety or effectiveness. Take the full label and medicine list to a qualified professional if considering use, particularly during pregnancy or breastfeeding.^{See reference 1,See reference 3}